Everence Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,060
| Closed | -$153 | – | 802 |
|
|
2024
Q2 | $153 | Hold |
10,060
| – | – | 0.01% | 717 |
|
|
2024
Q1 | $190 | Hold |
10,060
| – | – | 0.01% | 722 |
|
|
2023
Q4 | $192K | Hold |
10,060
| – | – | 0.01% | 709 |
|
|
2023
Q3 | $181 | Hold |
10,060
| – | – | 0.01% | 691 |
|
|
2023
Q2 | $207K | Hold |
10,060
| – | – | 0.02% | 638 |
|
|
2023
Q1 | $183 | Hold |
10,060
| – | – | 0.02% | 700 |
|
|
2022
Q4 | $208 | Hold |
10,060
| – | – | 0.02% | 683 |
|
|
2022
Q3 | $263K | Hold |
10,060
| – | – | 0.02% | 555 |
|
|
2022
Q2 | $255K | Buy |
+10,060
| New | +$255K | 0.02% | 566 |
|